News & Events

In this section

Eurofins Product Safety Labs Selects Provantis Preclinical Software to Automate NJ Research Facility

Provantis Chosen to Help Bring New Efficiencies for Collecting, Analyzing & Reporting Study Data

CONSHOHOCKEN, PA - (BUSINESS WIRE) – May 18, 2010 - - Instem®, a leading provider of early drug development software solutions, announced today that Eurofins Product Safety Labs (EPSL) has purchased an online subscription to the Provantis® Preclinical Software solution.

A contract research laboratory located in Dayton, New Jersey, EPSL provides a broad range of services including toxicology, analytical and bioanalytical chemistry and pharmacology.

During the second half of 2009, EPSL ran extensive competitive vendor evaluations with an emphasis on reproductive and fetal pathology. EPSL concluded that the Provantis solution, in conjunction with Instem’s tailored services, would propel them to the next level of operational effectiveness and customer-sponsor satisfaction.

EPSL will be using Instem’s Software-as-a-Service model allowing them to access Provantis over the Internet. Their online subscription includes all 3rd party licenses such as Oracle and SAS, along with training, maintenance, unlimited help desk support and Instem’s Validation Pack. Removing the need for on-site software ensures clients like EPSL can access the latest major releases of Provantis without the delays and costs sometimes involved with site-based installations.

Since 2005, Instem has utilized a state-of-the-art data center based in the US, which is being used by clients running GLP and non-GLP studies. 

“In addition to the benefits of their software solution, it’s obvious to me that Instem will become a true extension of our business, ensuring we receive the highest amount of value from our investment,”  states Gary Wnorowski, President of EPSL. “The approach they use allows our staff to learn the system at their own pace by leveraging features and functions that are tailored to our needs.  Automating with Provantis will additionally enable us to expand our services and conduct more complex and longer term studies.”

EPSL is also benefiting from Instem’s Specialized Solutions program, which is specifically designed for clients needing a more tailored approach to implementation, training, validation and support services. With dedicated client specialists and extended customer care, this program is perfect for smaller laboratories, those conducting research in academic or government settings, non-GLP environments or those running non-traditional toxicology studies.

The Specialized Solutions program features a Continuous Learning Model, helping users learn faster and retain more without the distractions and disruptions other vendors may cause during “deliver everything at once” implementations. Using this exclusive method, clients stay connected with Instem when they need them the most, which often is for one year following their first Provantis study. EPSL now has ON-demand access to educational industry experts to help with a new study design, more advanced learning or anything else that can maximize their use of Instem software solutions.

About Provantis®

Provantis is a modern, fully integrated software system for single users and global organizations engaged in preclinical evaluation studies. Orchestrating every facet of preclinical drug safety assessment, Provantis streamlines processes and workflows with straightforward, intuitive functionality for simple or complex studies within a GLP or non-GLP environment, on-site or over the Web.

About Eurofins Product Safety Labs (EPSL)

Eurofins Product Safety Labs provides research and testing services to the agrichemical, chemical, pharmaceutical, dietary supplement/functional foods, personal care, animal health, biotechnology and household product industries.  EPSL offers a broad range of services including toxicology, analytical and bioanalytical chemistry and pharmacology.

More information can be found at

About Instem

Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.

Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.

Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.

Meeting clients at the intersection of investment & return™.

Press Contacts:

Gary Mitchell (US HQ)
Tel: 610-941-0990

Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600